amad retweeted
The website is live at intro2echo.com and the github is at github.com/douyang/echodemo
It was really fun to make the free movement - the video doesn't do it justice, but you can free move both the TTE and TEE probe and it'll generate the 2D image in according to the 3D model.
There's a couple of chapters on common echo concepts and common diseases. Would love feedback!
I'm almost ready to share it, but Claude Code is very good at keeping consistency across views and chapters.
For example, I can specify a heart phenotype, and will make all the images consistent and physiologically plausible.
Even with unlimited time, I don't think I could create such a nice tutorial!
amad retweeted
🧵/ Our new total CV risk prediction tool, Predicting Risk of CV disease EVENTS (PREVENT) is now available: professional.heart.org/preve…
The calculator predicts risk for heart attack, stroke & heart failure.
✍🏽 @HeartDocSadiya @JoeCoresh @dmljmd @ChiadiNdumele @RangaswJ
More ⬇️🧵
🆕 This statement summarizes the background, rationale, and clinical implications for newly developed sex-specific, race-free risk equations: American Heart Association Predicting Risk of CVD EVENTs (PREVENT)
✍🏽 @HeartDocSadiya @JoeCoresh @dmljmd
🔗 spr.ly/6015utt1W
amad retweeted
Manage Cardiogenic Shock 2/2 Acute Myocardial Infarction like a pro! This is the (updated) protocol we’ve been using to manage ICU patients for years with fantastic results. 🎩 tip to the authors!
eddyjoemd.com/foamed/
amad retweeted
false positive EST not due to poor specificity of EST as a diagnostic test but from using obstructive CAD as reference standard for myocardial ischemia
When CMD by invasive physiological assessment used as reference standard,EST has 💯specificity bit.ly/3vqsE5P – at Pittsburgh, PA
amad retweeted
Frail AF is an excellent trial--w a surprising result that informs practice tomorrow
Great presentation from Dr. Linda Joosten
Take homes: 1) Be careful translating evidence to older pts with co-morbid conditions 2) Study uncertainties in RCTs -- it can be done #escccongress
Switching frail patients from warfarin to DOAC appears to be a bad idea according to the FRAIL-AF trial at. #ESCCongress. 69% more bleeds with DOAC (50% had rivaroxaban)
amad retweeted
The ACC has developed the point of care #ultrasound workbook to provide guidance on using POCUS in CV clinical practice.
🔑Key Points from the #POCUS Workbooks⬇️
amad retweeted
1/ #HFpEF treatment algorithm #tweetorial. This is the algorithm I currently use to treat HFpEF based on evidence we have thus far and my anecdotal experience treating patients over the past 16 years in the @NMCardioVasc HFpEF Clinic.
amad retweeted
Representing @BrownMedicine IM program at ACC.23! 🫀 @ACCinTouch @TiffanyHoMD @MohammedHajiMD @vishal_khetpal @AmadJChohan @gla_baji @CharlesFoxIV – at New Orleans, LA
amad retweeted
TOP 10 CARDIAC ARREST TRIALS OF 2022 🫀⚡️
What a year for resuscitation science! 💥
➡️ I collected and summarized in this infographic 10 must-read randomized trials published in 2022 in the fields of cardiac arrest and CPR
🔗 https://teapaw.org/t.co/KUpXJo4u59
#FOAMcc #ResusTwitter
amad retweeted
New cluster RCT in OHCA
🚑 DSED or vector-change in refractory VF
👉 Double sequential external defibrillation (rapid sequential shocks from 2 defibrillators) or switching pads to an A-P position
➡️ Higher survival for both techniques
🔗 nejm.org/doi/full/10.1056/NE…
#ResusTwitter
amad retweeted
Replying to @Manoj_Wickram
3 videos along the bottom from #echofirst queen @sharonmkay are my go for complex probe manipulation
intensivecarenetwork.com/mod…
amad retweeted
#AHA22 LBCTs one liners:
1. TRANSFORM-HF: Torsemide was not superior to furosemide in improving survival among patients treated for decompensated HF.
2. DCP: No differences in cardiovascular outcomes between chlorthalidone and HCTZ among elderly veterans with HTN.
amad retweeted
UPDATE: We're excited to announce that all Oklahomans will be eligible to receive the COVID-19 vaccine starting March 29. We encourage everyone to make an appointment for their vaccine as soon as possible through any of the available methods.




































